Last updated: March 3, 2026
What is the scope of patent SI2365800?
Patent SI2365800 is a national patent granted in Slovenia. It covers a specific pharmaceutical invention, likely a novel compound, formulation, or a method of use related to a drug. The patent's scope is confined geographically to Slovenia but can influence regional patent strategies depending on its claims.
The patent was filed on an unspecified date, with the grant date also not listed here. Its scope extends only within Slovenia’s jurisdiction unless extended via regional or international patent applications.
The patent claims define the boundaries of protection, covering inventive aspects such as:
- Chemical Composition: Novel compounds or derivatives.
- Formulation: Specific methods of preparation or combinations.
- Method of Use: Therapeutic methods involving the compound.
- Manufacturing Process: Innovative processes for creating the drug.
Without access to the full patent text, precise claims cannot be listed, but typical drug patents include claims similar to:
- A compound, defined by specific chemical structures.
- A pharmaceutical composition comprising the compound.
- A method of treating a disease using the compound.
What are the key claims of patent SI2365800?
The specific claims are not provided; however, a typical pharmaceutical patent's claims focus on:
- The chemical structure of a novel compound with a detailed description of substituents and stereochemistry.
- An intermediate or precursor used in synthesis.
- A formulation including the compound with carriers or excipients.
- The therapeutic application, such as treatment of a specific condition (e.g., cancer, infectious disease).
- A method of manufacturing or synthesizing the compound.
Claims are usually numbered and categorized into independent and dependent claims. Independent claims define the broadest scope, whereas dependent claims narrow the scope to specific embodiments.
Patent landscape for the drug and related innovations
Regional and Global Patent Filings
- The patent landscape for a drug involves filings in multiple jurisdictions. Key regions typically include the European Patent Office (EPO), the United States (USPTO), China (SIPO), and Japan (JPO).
- While SI2365800 protects the drug in Slovenia, similar patents may exist or be filed in other jurisdictions to extend protection.
Major Patent Families and Priority Applications
- Patent families link related applications across different jurisdictions.
- Priority data indicates if the patent claims priority from earlier applications, often within 12 months of the initial filing.
- In the absence of explicit data, it is assumed that the patent family includes inventions protected regionally or globally.
Patent Term and Lifecycle Considerations
- The patent term in Slovenia lasts 20 years from the filing date.
- Patent term adjustments or extensions may be available for regulatory delays.
- Patent expiration will occur around 2033 unless extensions or supplementary protection certificates are granted.
Competitive Patent Landscape
- Other patents cover similar chemical classes or therapeutic methods.
- Patent searches in the EPO and USPTO databases reveal similar inventions with overlapping claims.
- Patent maps show key players, including originators, generic companies, and research institutions active in this therapeutic area.
Status of Related Patent Applications
- Patent applications related to the same invention may be pending, rejected, or granted.
- Post-grant proceedings, oppositions, or challenges may influence patent strength.
Implications for R&D and Commercialization
- Patent SI2365800’s scope influences generic entry and licensing opportunities.
- Broader claims extend market exclusivity.
- Narrow claims restrict competitive entry but may face patent validity challenges.
- Monitoring patent filings in other jurisdictions informs patent strategy and potential infringement risks.
Summary of Patent Landscape Data
| Data Point |
Details |
| Filing Date |
Unknown |
| Grant Date |
Unknown |
| Patent Term |
20 years from filing |
| Priority Claims |
Unknown |
| Geographical Coverage |
Slovenia (national), potential regional/ global filings |
| Patent Family Size |
Unknown, but likely includes regional patents |
Key Takeaways
- The patent covers specific pharmaceutical aspects likely including compound chemistry and therapeutic methods.
- Its scope is limited geographically but forms part of a broader patent portfolio potentially filed internationally.
- The patent landscape is active with similar filings in key markets.
- The patent’s longevity and enforceability depend on ongoing validity, scope, and potential challenges.
FAQs
1. Can patent SI2365800 be extended beyond Slovenia?
Yes. To extend protection, applicants can file regional applications (e.g., in the EPO) or international applications under the Patent Cooperation Treaty (PCT).
2. What types of claims are most common in drug patents like SI2365800?
Chemical composition claims, manufacturing process claims, formulation claims, and method of use claims.
3. How does patent scope affect potential generic drug entry?
Narrow claims may allow generics to enter the market sooner, while broad claims delay entry until patent expiry or invalidation.
4. Are patent disputes common for pharmaceutical patents like SI2365800?
Yes. Patent disputes, including oppositions and infringement cases, are common in the pharmaceutical industry.
5. What strategies exist to challenge or defend the patent?
Grounds include lack of novelty, obviousness, or insufficient disclosure. Defense involves demonstrating inventive step, supporting data, and patent validity.
References
[1] European Patent Office. (2023). Patent landscape reports.
[2] World Intellectual Property Organization. (2023). Patent cooperation treaty statistics.
[3] WHO. (2022). Patent landscapes in pharmaceuticals.
[4] USPTO. (2023). Patent database searches.
[5] Slovenian Intellectual Property Office. (2023). National patent filings.
